Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. trimmed its stake in Agilent Technologies, Inc. (NYSE:A) by 75.3% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,454 shares of the medical research company’s stock after selling 31,934 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Agilent Technologies were worth $1,389,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of A. State Street Corp boosted its holdings in shares of Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after buying an additional 241,029 shares during the period. Geode Capital Management LLC raised its holdings in shares of Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares during the period. Morgan Stanley lifted its position in shares of Agilent Technologies by 15.9% in the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after acquiring an additional 692,202 shares in the last quarter. Norges Bank purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $549,158,000. Finally, Cantillon Capital Management LLC boosted its stake in Agilent Technologies by 0.8% in the 4th quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock worth $423,945,000 after purchasing an additional 23,493 shares during the period.

Piper Sandler started coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. TD Cowen raised their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Jefferies Financial Group started coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Finally, Robert W. Baird increased their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th.

Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies stock opened at $148.55 on Friday. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market cap of $41.95 billion, a P/E ratio of 29.83, a P/E/G ratio of 2.64 and a beta of 1.25. The company’s fifty day simple moving average is $135.38 and its 200-day simple moving average is $125.56.